(Q35735559)

10 August 2017

1 reference

title

Melanoma of the head and neck: current concepts in staging, diagnosis, and management (English)

1 reference

10 August 2017

Maher N Younes

1

1 reference

10 August 2017

Jeffrey N Myers

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

Surgical oncology clinics of North America

10 August 2017

published in

1 reference

10 August 2017

volume

13

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

201-229

1 reference

10 August 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Analysis of survival and disease control in stage I melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

1 reference

7 January 2021

Wavelengths effective in induction of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Why ultraviolet protection with clothing makes sense

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Sunscreens: safety, efficacy and appropriate use.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Summer sunburn and sun exposure among US youths ages 11 to 18: national prevalence and associated factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Risk factors for the development of malignant melanoma--I: Review of case-control studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Epidemiology and prognostic factors in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

High risk of malignant melanoma in melanoma-prone families with dysplastic nevi

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Germline p16 mutations in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Xeroderma pigmentosum and related disorders: examining the linkage between defective DNA repair and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Defective Repair Replication of DNA in Xeroderma Pigmentosum

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma)

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Who discovers melanoma? Patterns from a population-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Early detection of malignant melanoma: the role of physician examination and self-examination of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

The importance of anatomic site in prognosis in patients with cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Primary cutaneous melanoma. Prognostic classification of anatomic location.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Malignant melanoma of the skin of the head and neck. An analysis of 405 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Malignant Melanoma of the Scalp

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Cutaneous melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

The new melanoma staging system

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

A new American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

The revised American Joint Committee on Cancer staging system for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Pathologic staging of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Classification and staging of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

The use of lymphoscintigraphy and PET in the management of head and neck melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

9:45-10:00. Positron Emission Tomography (PET) is Superior to Computerized Tomography (CT) for Metastatic Staging in Melanoma Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Effectiveness of positron emission tomography for the detection of melanoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Posterolateral neck dissection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Sentinel lymph node biopsy in melanoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Localization of regional lymph nodes in melanomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Postoperative radiotherapy for cutaneous melanoma of the head and neck region.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Regional therapy of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) Surgical Adjuvant Study COG PROTOCOL 7040.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Adjuvant interferon treatment for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Recombinant BCG therapy suppresses melanoma tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Adjuvant therapy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Vaccines for melanoma: translating basic immunology into new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Recurrent cutaneous melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Follow-up in stage I cutaneous malignant melanoma: an audit

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Mucosal melanomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Primary mucosal malignant melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Mucosal melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Desmoplastic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

The clinical behavior of desmoplastic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Desmoplastic melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Desmoplastic melanoma: patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Desmoplastic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Desmoplastic melanoma. Histologic correlation with behavior and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

Melanoma metastatic to cervical and parotid nodes from an unknown primary site.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900125-X

7 January 2021

10.1016/S1055-3207(03)00125-X

Identifiers

DOI

1 reference

10 August 2017

1 reference